| Literature DB >> 33895845 |
Jan Steffel1, Ronan Collins2, Matthias Antz3, Pieter Cornu4, Lien Desteghe5,6, Karl Georg Haeusler7, Jonas Oldgren8, Holger Reinecke9, Vanessa Roldan-Schilling10, Nigel Rowell11, Peter Sinnaeve12, Thomas Vanassche12, Tatjana Potpara13, A John Camm14, Hein Heidbüchel5,6, Gregory Y H Lip15,16,17, Thomas Deneke18, Nikolaos Dagres19, Giuseppe Boriani20, Tze-Fan Chao21, Eue-Keun Choi22, Mellanie True Hills23, Itamar de Souza Santos24,25, Deirdre A Lane15,16,17, Dan Atar26,27, Boyoung Joung28, Oana Maria Cole15,16, Mark Field15,16.
Abstract
Entities:
Keywords: DOACs; NOACs; apixaban; dabigatran; edoxaban; rivaroxaban
Year: 2021 PMID: 33895845 DOI: 10.1093/europace/euab065
Source DB: PubMed Journal: Europace ISSN: 1099-5129 Impact factor: 5.214